Poland· PL-100050756
Oxsoralen
A methoxsalen product containing 8-methoxypsoralenum, registered in Poland by G.L. Pharma GmbH. The same ATC class is registered in 9 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Methoxsalen is registered in 9 of 19 countries.
Countries holding a registration under ATC D05BA02 (methoxsalen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Methoxsalen · ATC D05BA02
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- 8-Methoxypsoralenum
- Manufacturer
- G.L. Pharma GmbH
- Country
- Poland (PL)
- ATC code
- D05BA02
- ATC class
- Methoxsalen
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- June 28, 2026
Packs & prices · 1
- gtin05909990244713
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for methoxsalen.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methoxsalen · interactions on record
3 records
- 1 severe
- 2 moderate
Most severe, free to view
- Aminolevulinic acidL01XD04severe
- Porfimer sodiumL01XD01moderate
- VerteporfinS01LA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under D05BA02
Methoxsalen, as other registers publish it.
- United Kingdom8-Methoxypsoralen 0.005% gelSpecial Order
- NorwayMeladinineXion
- United StatesMethoxsalenStrides Pharma Science Limited
- United KingdomMethoxsalen 0.005% gelSpecial Order
- United KingdomMethoxsalen 0.15% paintSpecial Order
- United KingdomMethoxsalen 0.15% topical emulsionSpecial Order
- United KingdomMethoxsalen 1% paintSpecial Order
- BelgiumMopsoralen 10 mgCeres Pharmaceuticals
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/adda64d1-ca54-467c-9b36-fdc42fb487d8 GET /v1/drugs/adda64d1-ca54-467c-9b36-fdc42fb487d8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki miękkie",
"source": "urpl",
"strength": "10 mg",
"packaging": "05909990244713 ¦ Rp ¦ 7613\n50 kaps.",
"substance": "8-Methoxypsoralenum 10 mg",
"common_name": "8-Methoxypsoralenum",
"pl_product_id": "100050756",
"pozwolenie_nr": "02447",
"auth_procedure": "NAR",
"authorisation_validity": "2023-06-30"
}See everything about methoxsalen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.